Shanghai Institute Of Materia Medica Chinese Academy of Sciences
发明人:
申请号：
EP15751703.8
公开号：
EP3112351A4
申请日:
2015.02.15
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to a naphthylamide compound of the structure as represented by formula (I), medicinal salts, prodrugs and hydrates or solvates thereof, and also relates to a method of preparing the compounds, pharmaceutical compositions comprising the compounds and the uses thereof as protein tyrosine kinase inhibitors, particularly as VEGFR-2 inhibitors, in preparing drugs for preventing and treating diseases related to abnormal angiogenesis.
